Supreme Court Rejects Purdue Pharma Opioid Settlement
By Robin Foster HealthDay Reporter
FRIDAY, June 28, 2024 (HealthDay News) -- The U.S. Supreme Court on Thursday struck down a controversial settlement that drug...
Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received Them
Higher percentages of men and adults aged 35 to 49 years received medications for opioid use disorder
Magic Mushroom’s Psilocybin Is America’s Most Popular Hallucinogen
By Carole Tanzer Miller HealthDay Reporter
THURSDAY, June 27, 2024 (HealthDay News) -- As psilocybin mushrooms become the most popular psychedelic in the United States,...
Health Status, Mental Health Worsened in U.S. Transgender Adults From 2014 to 2022
Doubling seen for prevalence of frequent mental distress and depression
ADHD Meds May Help Control Opioid Use Disorder in Pregnancy
Additional benefits include increased buprenorphine initiation, decreased methadone initiation, and improved buprenorphine retention
Semaglutide Cuts Incidence, Recurrence of Alcohol Use Disorder
Findings show risk cut in half based on electronic health record data
Home-Administered Treatment Shows Promise for Binge Eating
Finding for 10 sessions of transcranial direct current stimulation with attention bias modification training
SNP rs13194504 AA Genotype Linked to Severity of Tardive Dyskinesia
AA genotype linked to reduced severity, but not occurrence, of TD; no association seen for rs210133 with TD occurrence, severity
U.S. Surgeon General Declares Gun Violence a Public Health Emergency
By Robin Foster HealthDay Reporter
TUESDAY, June 25, 2024 (HealthDay News) -- Gun violence in the United States has become a national public health crisis,...
FDA’s Move to OK First Menthol Vapes Is Big Mistake, Health Advocates Say
By Robin Foster HealthDay Reporter
MONDAY, June 24, 2024 (HealthDay News) -- The U.S. Food and Drug Administration's decision to authorize the first menthol-flavored e-cigarettes...
